Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia (Q33880828)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia |
scientific article |
Statements
1 reference
Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia (English)
1 reference
J E Cortes
1 reference
F Ravandi
1 reference
C Arana Yi
1 reference
M Levis
1 reference
S Faderl
1 reference
G Garcia-Manero
1 reference
E Jabbour
1 reference
M Konopleva
1 reference
S O'Brien
1 reference
Z Estrov
1 reference
G Borthakur
1 reference
D Thomas
1 reference
S Pierce
1 reference
M Brandt
1 reference
K Pratz
1 reference
R Luthra
1 reference
M Andreeff
1 reference
H Kantarjian
1 reference
3 February 2014
1 reference
1 reference
28
1 reference
1543-1545
1 reference
Identifiers
1 reference
1 reference
1 reference